Skip to main content

Fabrizio Esquivel Segovia

Institutions of which they are part

Research technician
Rheumatology
Vall Hebron Institut de Recerca

Fabrizio Esquivel Segovia

Institutions of which they are part

Research technician
Rheumatology
Vall Hebron Institut de Recerca

Related news

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

The event, held as part of World Lupus Day, incorporated the perspective of people living with the disease to address the challenges associated with lupus.

The global biopharmaceutical company UCB has acquired the data and clinical knowledge business of IMIDomics, a spin-off of the Vall d’Hebron Institute of Research (VHIR).

Related professionals

Sergio Lopez Gandul

Sergio Lopez Gandul

Research assistant
Molecular Imaging and Therapy
Read more
Xavier Bartolome Payra

Xavier Bartolome Payra

Gestió i Administració
Fundraising Unit
Communication Directorate
Read more
Teresa González Alujas

Teresa González Alujas

Cardiovascular Diseases
Read more
Aina García Martínez

Aina García Martínez

Predoctoral researcher
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.